Nuo Therapeutics, Inc. 4
4 · Nuo Therapeutics, Inc. · Filed Jan 11, 2017
Insider Transaction Report
Form 4
CLAUSEN PETER
CSO/COO
Transactions
- Award
Option to purchase Common Stock
2017-01-09+80,000→ 80,000 totalExercise: $1.00Exp: 2026-07-01→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]The grant of these options was approved by the issuer's board of directors on July 1, 2016, subject to stockholder approval of the 2016 Omnibus Incentive Compensation Plan under which the options were granted. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on November 25, 2016. The stockholder approval became effective on January 9, 2017. The option grant disclosed herein does not include options to purchase 95,000 shares subject to performance conditions, which have not yet vested and are therefore not yet reportable on Form 4.
- [F2]Of these options, 40,000 vested on 9/29/16 and 40,000 will vest on 12/31/17.